Home - Syndax

Determined to realize a future in which people with cancer live longer and better than ever before.

Clinical Trials

09.15.21

Syndax Appoints Martin H. Huber, M.D., to its Board of Directors

09.02.21

Syndax Announces Participation at Three Upcoming Investor Conferences

08.09.21

Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update

08.02.21

Syndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021